BioNTech SE

{ "date": [ "202612", "202712", "202812" ], "revenue_estimate": [ 2583.31, 2712.11, 2956.71 ], "ebit_estimate": [ -1600.92, -1694.7, -1532.45 ], "ebitda_estimate": [ -1280.96, -1398.9, -1253.02 ], "net_income_estimate": [ -1212.42, -1277.69, -1019.32 ], "per_share_eps_estimate": [ -5.36, -5.28, -4.5 ], "eps_nri_estimate": [ -5.12, -4.82, -3.99 ], "dividend_estimate": [ null, null, null ], "book_value_per_share_estimate": [ 72.06, 78.79, 79.64 ], "pretax_income_estimate": [ -1203.53, -1281.42, -993.13 ], "operating_cash_flow_per_share_estimate": [ -6.52, -6.68, -2.59 ], "roa_estimate": [ -5.77, -7.23, -5.4 ], "roe_estimate": [ -7, -8.09, -5.35 ], "gross_margin_estimate": [ 83.23, 84.09, 81.75 ], "operating_cash_flow_estimate": [ -1592.35, -1631.66, -632.7 ], "pettm_estimate": [ 0, 0, 0 ], "long_term_growth_rate_mean": -78.91, "long_term_revenue_growth_rate_mean": "0.00", "future_per_share_eps_estimate_growth": 6.02, "future_eps_nri_estimate_growth": -78.91, "future_revenue_estimate_growth": null, "future_ebit_estimate_growth": -7.86, "future_ebitda_estimate_growth": -16.96, "future_dividend_estimate_growth": null, "future_net_income_estimate_growth": 7.19, "future_pretax_income_estimate_growth": 5.63, "future_book_value_per_share_estimate_growth": null, "future_roa_estimate_growth": null, "future_roe_estimate_growth": null, "future_gross_margin_estimate_growth": null, "future_operating_cash_flow_per_share_estimate_growth": null }

{ "date": [ "202603", "202606", "202609", "202612", "202703", "202706", "202709", "202712" ], "revenue_estimate": [ 189.29, 202.1, 1343.63, 844.15, null, null, null, null ], "ebit_estimate": [ -777.81, -790.95, 103.42, -303.82, null, null, null, null ], "ebitda_estimate": [ -637.14, -678.99, 210.26, -369.9, null, null, null, null ], "net_income_estimate": [ -666.86, -670.71, 180.9, -411.62, null, null, null, null ], "per_share_eps_estimate": [ -2.78, -2.78, 0.65, -1.29, -1.74, -1.81, -1.45, 3.68 ], "eps_nri_estimate": [ -2.61, -2.64, 0.99, -0.9, -1.74, -1.81, -1.45, 3.68 ], "dividend_estimate": [ null, null, null, null, null, null, null, null ], "book_value_per_share_estimate": [ -2.73, -2.78, -1.39, 0.25, null, null, null, null ], "pretax_income_estimate": [ -676.65, -676.52, 149.42, -475.04, null, null, null, null ], "operating_cash_flow_per_share_estimate": [ null, null, null, null, null, null, null, null ], "roa_estimate": [ null, null, null, null, null, null, null, null ], "roe_estimate": [ null, null, null, null, null, null, null, null ], "gross_margin_estimate": [ null, null, null, null, null, null, null, null ], "operating_cash_flow_estimate": [ null, null, null, null, null, null, null, null ], "pettm_estimate": [ 0, 0, 0, 0, 0, null, null, null ], "long_term_growth_rate_mean": -78.91, "long_term_revenue_growth_rate_mean": "0.00", "future_per_share_eps_estimate_growth": 6.02, "future_eps_nri_estimate_growth": -78.91, "future_revenue_estimate_growth": null, "future_ebit_estimate_growth": -7.86, "future_ebitda_estimate_growth": -16.96, "future_dividend_estimate_growth": null, "future_net_income_estimate_growth": 7.19, "future_pretax_income_estimate_growth": 5.63, "future_book_value_per_share_estimate_growth": null, "future_roa_estimate_growth": null, "future_roe_estimate_growth": null, "future_gross_margin_estimate_growth": null, "future_operating_cash_flow_per_share_estimate_growth": null }